Blog
From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.
By James Lu, MD, PhD, CEO and Co-Founder of Helix
The Latest Content From Helix
Recent Blog Posts
View All Blog Posts
Recent Press Releases
View All Press ReleasesPress Releases
Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments
Press Releases
Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development
Press Releases
Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward
Recent Videos
View All Videos
Recent Published Research
View All Published Research1
Published Research
Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project
2
Published Research
Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60
3
Published Research
Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions
4
Published Research
Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia
5
Published Research
